v3.25.2
Segment Information - Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]            
Segment and consolidated net loss $ 23,092 $ 22,970 $ 17,487 $ 13,311 $ 46,062 $ 30,798
Reportable Segment            
Segment Reporting Information [Line Items]            
Research and development payroll-related costs 5,089   4,253   10,321 7,281
General and administrative payroll-related costs 2,003   1,750   4,156 3,299
Clinical trial expenses 6,023   3,043   12,032 5,238
Chemistry, manufacturing, and controls costs 3,124   5,842   7,470 10,235
Medical affairs expenses 977   657   1,532 944
Research and development consulting expenses 1,537   948   2,910 1,779
General and administrative consulting expenses 1,302   1,605   2,338 3,595
Other segment items 3,037   (611)   5,303 (1,573)
Segment and consolidated net loss $ 23,092   $ 17,487   $ 46,062 $ 30,798